Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence and Booster of MenB Vaccine in Adolescents
NCT02446743Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2015
- Primary completion
- Sep 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of recombinant neisseria meningitidis group B nhba fusion protein in meningococcal group B infection (MenB), sponsored by GSK. Started Nov 2015; status: completed.
02
Drugs
recombinant neisseria meningitidis group B nhba fusion protein
03
Conditions
meningococcal group B infection (MenB)
Beyond the preview
Go deeper on NCT02446743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446743.